-
1 Comment
Boill Healthcare Holdings Limited is currently in a long term downtrend where the price is trading 7.9% below its 200 day moving average.
From a valuation standpoint, the stock is 48.8% cheaper than other stocks from the Real Estate sector with a price to sales ratio of 3.0.
Boill Healthcare Holdings Limited's total revenue sank by 69.9% to $20M since the same quarter in the previous year.
Its net income has dropped by 18.9% to $-71M since the same quarter in the previous year.
Finally, its free cash flow fell by 85.5% to $15M since the same quarter in the previous year.
Based on the above factors, Boill Healthcare Holdings Limited gets an overall score of 1/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | KYG1225S1167 |
| Sector | Real Estate |
| Industry | Real Estate - Development |
| PE Ratio | None |
|---|---|
| Target Price | None |
| Beta | 0.29 |
| Market Cap | 29M |
| Dividend Yield | None |
Boill Healthcare Holdings Limited, an investment holding company, undertakes contracts for foundation piling in Hong Kong and Mainland China. The company develops and sells properties, as well as provides property management services. It also trades and invests in securities. The company was formerly known as Ngai Shun Holdings Limited and changed its name to Boill Healthcare Holdings Limited in September 2017. Boill Healthcare Holdings Limited is based in Kowloon Bay, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1246.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
